Published in N Engl J Med on August 08, 1985
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. J Clin Immunol (2001) 1.75
Trial watch: Monoclonal antibodies in cancer therapy. Oncoimmunology (2013) 1.41
Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation. Pediatr Nephrol (2011) 1.40
Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc (1987) 1.36
Trial Watch: Monoclonal antibodies in cancer therapy. Oncoimmunology (2012) 1.34
Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J Exp Med (1997) 1.33
Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs (2011) 1.24
Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial. BMJ Open (2014) 1.01
Superantigens in human disease. J Clin Immunol (1999) 0.88
Therapeutic strategies with monoclonal antibodies and immunoconjugates. Immunology (1988) 0.87
Novel human antibody therapeutics: the age of the Umabs. Biotechnol J (2008) 0.84
Immunosuppressive drug therapy. Cold Spring Harb Perspect Med (2013) 0.83
High affinity humanized antibodies without making hybridomas; immunization paired with mammalian cell display and in vitro somatic hypermutation. PLoS One (2012) 0.83
Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications. Blood (2012) 0.80
CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic. Rev Diabet Stud (2012) 0.80
Infections in pediatric liver recipients treated for acute rejection. Transplant Proc (1989) 0.78
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody. Clin Exp Immunol (2003) 0.78
Modulation of the human T cell response by a novel non-mitogenic anti-CD3 antibody. PLoS One (2014) 0.78
Liver transplantation(). J Ultrasound (2007) 0.77
Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation. Clin Exp Immunol (2001) 0.77
Teplizumab therapy for type 1 diabetes. Expert Opin Biol Ther (2010) 0.76
Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naïve baboons. Transpl Immunol (2013) 0.76
T cell activation alters intestinal structure and function. J Clin Invest (2006) 0.76
Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies. BMC Biotechnol (2017) 0.75
Infections in patients receiving OKT3 monoclonal antibody for cardiac rejection: results of a small clinical trial. Tex Heart Inst J (1988) 0.75
Immunosuppressive Medications. Clin J Am Soc Nephrol (2015) 0.75
Prophylactic use of OKT3 in liver transplantation. A review. Dig Dis Sci (1991) 0.75
Biologics in the prevention and treatment of graft rejection. Springer Semin Immunopathol (2006) 0.75